Page last updated: 2024-08-26

arsenic and diazeniumdiolate

arsenic has been researched along with diazeniumdiolate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonifant, CL; Buzard, GS; Keefer, LK; Leslie, E; Li, C; Liu, J; Qu, W; Saavedra, JE; Waalkes, MP	1

Other Studies

1 other study(ies) available for arsenic and diazeniumdiolate

Article	Year
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Molecular cancer therapeutics, 2004, Volume: 3, Issue:6 Topics: Animals; Arsenic; Azo Compounds; Cell Line; Cisplatin; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide Donors; Phosphorylation; Piperazines; Platinum; Prodrugs; Rats	2004

Article

Year

Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation.

Molecular cancer therapeutics, 2004, Volume: 3, Issue:6

Topics: Animals; Arsenic; Azo Compounds; Cell Line; Cisplatin; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide Donors; Phosphorylation; Piperazines; Platinum; Prodrugs; Rats

2004